Company facts
- Headquarters
- Iselin, New Jersey
- Most recent report
- 10-Q, filed Aug 18, 2026
- Incorporated
- Delaware
- Filings on record
- 827 filings
- On EDGAR
- CIK 1649989
- Fiscal year ends
- September
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 48
News 8 of 174
Prospectuses and Registrations 8 of 106
- 424B5 Prospectus supplement for an offering Aug 14, 2026
- 424B5 Prospectus supplement for an offering Aug 12, 2026
- 424B3 Prospectus supplement for an offering Jul 21, 2026
- S-3 Shelf registration statement Jul 17, 2026
- 424B5 Prospectus supplement for an offering May 29, 2026
- 424B5 Prospectus supplement for an offering May 13, 2026
- 424B5 Prospectus supplement for an offering Apr 23, 2026
- 424B5 Prospectus supplement for an offering Mar 25, 2026
Proxies 8 of 28
- DEFA14A Extra proxy material Jul 10, 2026
- DEFA14A Extra proxy material Jun 1, 2026
- DEF 14A Proxy statement for a shareholder vote Jun 1, 2026
- PRE 14A Preliminary proxy statement May 22, 2026
- DEFA14A Extra proxy material Jan 26, 2026
- DEF 14A Proxy statement for a shareholder vote Jan 26, 2026
- DEF 14A Proxy statement for a shareholder vote Feb 10, 2025
- PRE 14A Preliminary proxy statement Jan 31, 2025
Ownership 8 of 369
- SCHEDULE 13G Large holder reported a passive stake Aug 19, 2026
- 4 Insider reported a trade Aug 14, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Jul 29, 2026
- 4 Insider reported a trade Jul 23, 2026
- 4 Insider reported a trade Jul 23, 2026
Other 8 of 102
- NT 10-Q Notice that a quarterly report will be late Aug 17, 2026
- EFFECT Notice that a registration became effective Jul 21, 2026
- DRS Draft registration statement, submitted confidentially Jul 8, 2026
- D May 7, 2026
- ARS Annual report sent to shareholders Jan 26, 2026
- EFFECT Notice that a registration became effective Mar 28, 2025
- CORRESP Reply to SEC staff Mar 26, 2025
- UPLOAD Comment letter from SEC staff Mar 26, 2025
Everything here comes from Outlook Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.